Blue Sky Uranium Corp. — Capital/Financing Update 2021

Aug 9, 2021

Form 51-102F3 MATERIAL CHANGE REPORT

Item 1. Name and Address of Reporting Issuer

Blue Sky Uranium Corp. (the “ Company ” or “ Blue Sky ”) Suite 312, 837 West Hastings Street Vancouver BC V6C 3N6

Item 2. Date of Material Change

August 5, 2021

Item 3. News Release

A News Release dated August 5, 2021 was disseminated via CNW.

Item 4. Summary of Material Changes

A summary of the nature and substance of the material change is as follows:

Blue Sky Uranium Amends Final Tranche of Non-Brokered Private Placement

Item 5. Full Description of Material Change

5.1 Full Description of Material Change

The Company announced that it had increased the final tranche of the non-brokered private placement financing as announced on July 30, 2021 to 13,316,089 units at a price of $0.16 per unit for total gross process of $2,130,574.24.

Each Unit consists of one common share and one transferrable common share purchase warrant (“Warrant”). Each Warrant in this 3[rd] and final tranche will entitle the holder thereof to purchase one additional common share in the capital of the Company at $0.25 per share for two (2) years from the date of issue, expiring on August 5, 2023.

There were no finder’s fees payable in this 3[rd] and final tranche. In total, cash finder’s fees of $49,002.80 were paid and 306,268 Finder’s Warrants were issued.

Certain insiders of the Company participated in the Private Placement for $7,200 in Units. Such participation represents a related-party transaction under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (“ MI 61-101 ”), but the transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of the subject matter of the transaction, nor the consideration paid, exceed 25% of the Company’s market capitalization.

The proceeds of the financing will be used for exploration programs on the Company’s projects in Argentina and for general working capital.

This financing is subject to regulatory approval and all securities to be issued pursuant to this 3[rd] and final tranche of the financing are subject to a four-month hold period expiring on December 5, 2021.

5.2 Disclosure for Restructuring Transactions

Not applicable.

Item 6. Reliance on subsection 7.1(2) of National Instrument 51-102

Not applicable.

Item 7. Omitted Information

Not applicable

Item 8. Executive Officer

For further information, please contact Nikolaos Cacos at (604) 687-1828 .

Item 9. Date of Report August 9, 2021